A new pain management protocol for prevention of postoperative delirium

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10001101

Enrollment

Unknown

Registered

2010-09-03

Start date

2011-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative analgesia and delirium

Interventions

treat group:The PCA regimen and administration protocol same as control group, additionally use parecoxib

control group:Morphine 0.5 mg/ml, total 100ml, background infusion rate 1ml/h, block time of 6min, patient controlled dosage of 2ml.

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients who agree to join in this trail; 2. Age over 60-years-old; 3. Patients who accept selective hip surgery or total knee arthroplasty

Exclusion criteria

Exclusion criteria: 1. Who refused to join in this trial; 2. ASA class IV grade; 3. NYHA IV grade; 4. Poor heart function (LVEF=10); 8. Previous history: cerebral vascular accident, peptic ulcers, or myocardial ischemia or infarction or heart failure. 9. Who was enrolled in other trials simultaneously; 10. For other exclusion reasons diagnosed by researchers.

Design outcomes

Primary

Measure	Time frame
postoperative surgical complications;	—

Secondary

Measure	Time frame
incidence of delirium;postoperative 28-day mortality;	—

Countries

China

Contacts

Public ContactMu Dong-liang

mudongliang@gmail.com+86 13810702725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026